Fleishman-Hillard Vanguard provided support for Reckitt Benckiser in organizing a press tour of the Russian mass-media to London. Within the trip journalists were told about basic methods of cold treatment in Great Britain and visited the leading virus researcher and creator of antiviral preparations in Europe– Retroscreen Virology.
Reckitt Benckiser Great Britain supports Retroscreen Virology in its unique research and work on the creation of a new generation of antiviral preparations and vaccines for treatment of a variety of infections. Representatives of the mass media were given a unique possibility to visit the laboratory where the latest antiviral drugs are tested, and to get personally acquainted with John Oxford, President, Scientific Director and founder of Retroscreen Virology Ltd.
PR support for Reckitt Benckiser in Russia is provided by Fleishman-Hillard Vanguard.
Reckitt Benckiser – the world leading manufacturer of house cleaners, health and personal hygiene products. It was founded in 1999 with the merger of Reckitt&Colman and Benckiser. In Russia the representative office of Benckiser has been working since 1996. Reckitt Benckiser is represented by 19 world famous brands: Airwick, Bang, Calgon, Clearasil, Dettol, Durex, Finish, French’s, Harpic, Lysol, Mortein, Mucinex, Nurofen, Scholl, Strepsils, Vanish, Veet, and Woolite. Every day across the world around 16 million products under the RB logo are on sale and take the leading position in the FMCG sector.
Thanks to a high level of innovation, the Reckitt Benckiser company takes first position in the quickly growing commodities market. On average 35% of the company’s income is derived from innovative projects. Since 2000 the sales volume of Reckitt Benckiser has more than doubled, and the company’s market capitalization has increased more than four times. The company’s net profit in 2010 was over £8.4 billion.